Rentokil Net Working Capital from 2010 to 2026
| RTO Stock | USD 31.74 0.01 0.03% |
Net Working Capital | First Reported 2010-12-31 | Previous Quarter -439.2 M | Current Value -417.2 M | Quarterly Volatility 213.3 M |
Macro event markers
This statements view for Rentokil Initial organizes long-term performance signals with capital structure context. The series highlights drivers like Depreciation And Amortization of 439.8 M, Interest Expense of 53.8 M or Total Revenue of 5.4 B and ratios such as Price To Sales Ratio of 2.46, Dividend Yield of 0.0185 or PTB Ratio of 2.9, complementing Rentokil Initial Valuation and Volatility.
Rentokil | Net Working Capital | Build AI portfolio with Rentokil Stock |
Evaluating Rentokil Initial's Net Working Capital across multiple reporting periods reveals the company's ability to sustain growth and manage resources effectively. This longitudinal analysis highlights inflection points, cyclical patterns, and structural changes that short-term snapshots might miss, offering deeper insight into Rentokil Initial PLC's fundamental strength.
Latest Rentokil Initial's Net Working Capital Growth Pattern
Below is the plot of the Net Working Capital of Rentokil Initial PLC over the last few years. It is Rentokil Initial's Net Working Capital historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Rentokil Initial's overall financial position and show how it may be relating to other accounts over time.
| Net Working Capital | 10 Years Trend |
|
Net Working Capital |
| Timeline |
Rentokil Net Working Capital Regression Statistics
| Arithmetic Mean | -94,602,353 | |
| Coefficient Of Variation | -225.49 | |
| Mean Deviation | 127,636,678 | |
| Median | -97,300,000 | |
| Standard Deviation | 213,316,401 | |
| Sample Variance | 45503.9T | |
| Range | 882M | |
| R-Value | -0.20 | |
| Mean Square Error | 46504.1T | |
| R-Squared | 0.04 | |
| Significance | 0.43 | |
| Slope | -8,646,127 | |
| Total Sum of Squares | 728062.2T |
Rentokil Net Working Capital History
About Rentokil Initial PLC
Rentokil Initial plc, together with its subsidiaries, provides route-based services in North America, the United Kingdom, rest of Europe, Asia, the Pacific, and internationally. Rentokil Initial plc was founded in 1903 and is headquartered in Crawley, the United Kingdom. Rentokil Initial operates under Specialty Business Services classification in the United States and is traded on New York Stock Exchange. It employs 46000 people. Downside history and drawdown behavior provide context for risk expectations in Rentokil Initial. Downside profile remains relatively contained. Rentokil Initial has a market cap of 16.32 B, P/E of 38.73, ROE of 5.19%. 
Gabriel Shpitalnik ยท Member of Macroaxis Editorial Board
Methodology
Unless otherwise specified, financial data for Rentokil Initial PLC is derived from periodic company reporting (annual and quarterly where available). Asset-level metrics are computed daily by Macroaxis LLC and refreshed regularly based on asset type. Rentokil (USA Stocks:RTO) prices are typically delayed by approximately 20 minutes from primary exchanges for listed equities. Data may be delayed depending on reporting sources and market conventions. Assumptions: The data underlying this report is sourced from public filings and market reference sources, including filings and releases published by U.S. Securities and Exchange Commission (SEC) via EDGAR. Some updates may be delayed based on publication cadence. All analytics are generated using standardized, rules-based models designed to promote consistency and comparability across instruments. Model assumptions, reference parameters, and selected computational inputs are available in the Model Inputs section. If you have questions about our data sources or methodology, please contact Macroaxis Support.
Analyst Sources
Rentokil Initial PLC is covered by 4 analysts. 2 analysts have submitted revenue and/or earnings estimates that may be incorporated into Macroaxis consensus inputs where available. Representative analyst firms may include Evercore ISI, Morgan Stanley, BMO Capital Markets, Oppenheimer & Co., Guggenheim Securities, among others. Updates may occur throughout the day.
Rentokil Stock is Curated By:
Gabriel Shpitalnik ยท Member of Macroaxis Editorial BoardPair Trading with Rentokil Initial
Pair trading with Rentokil Initial can help investors hedge some company-specific exposure by balancing a long view with an offsetting position. The key question is whether the second leg adds real hedge value instead of just creating a more complex version of the same risk.
Moving together with Rentokil Stock
The information in the correlation table below can inform Rentokil Initial tax-loss harvesting decisions, showing which instruments historically move in lockstep with Rentokil Initial PLC and can serve as viable temporary replacements.
Negative correlation assets provide natural hedges against Rentokil Initial positions. When Rentokil Initial PLC's value declines, a negatively correlated instrument tends to rise, partially offsetting portfolio losses.
Pair evaluation and Correlation analysis for Rentokil Initial provide hedging context. This approach is commonly reviewed within sectors and across broader groups.More Resources for Rentokil Stock Analysis
A structured review of Rentokil Initial PLC often starts with core financial statements and trend context. Key ratios help frame profitability, efficiency, and growth context for Rentokil Initial PLC Stock. Highlighted below are reports that provide context for Rentokil Initial PLC Stock:Compare Rentokil Initial against competitors using Rentokil Initial Correlation. This supports competitive context. Analysis related to Rentokil Initial should be read together with other portfolio and risk tools before capital is reallocated. That is especially important when the goal is to improve the overall mix of instruments already held. You can also try the Commodity Channel module to use Commodity Channel Index to analyze current equity momentum.
Quarterly Earnings Growth 0.883 | Dividend Share 0.124 | Earnings Share 0.57 | Revenue Per Share | Quarterly Revenue Growth -0.04 |
Investors evaluate Rentokil Initial PLC using market value and book value, each describing different facets of the business. Rentokil Initial's market capitalization is 16.32 B. A P/B ratio of 2.91 indicates the market values Rentokil Initial above its accounting book value. Enterprise value stands at 19.59 B. Intrinsic value is an estimate of what Rentokil Initial's fundamentals imply, and it may differ from market and book figures. Analytical frameworks help compare those viewpoints.
Value and price for Rentokil Initial are related but not identical, and they can diverge across cycles. For Rentokil Initial, key inputs include a P/E ratio of 38.73, a P/B ratio of 2.91, a profit margin of 6.8%, and ROE of 5.19%. By contrast, market price reflects the level where buyers and sellers transact.